ALXN
T. Rowe Price Associates’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-725,032
| Closed | -$133M | – | 3027 |
|
|
2021
Q2 | $133M | Sell |
725,032
-67,287
| -8% | -$12.4M | 0.01% | 686 |
|
|
2021
Q1 | $121M | Sell |
792,319
-743,854
| -48% | -$114M | 0.01% | 710 |
|
|
2020
Q4 | $240M | Sell |
1,536,173
-1,579,562
| -51% | -$247M | 0.02% | 479 |
|
|
2020
Q3 | $357M | Sell |
3,115,735
-4,324,105
| -58% | -$495M | 0.04% | 359 |
|
|
2020
Q2 | $835M | Sell |
7,439,840
-1,102,845
| -13% | -$124M | 0.11% | 200 |
|
|
2020
Q1 | $767M | Sell |
8,542,685
-3,563,213
| -29% | -$320M | 0.12% | 176 |
|
|
2019
Q4 | $1.31B | Buy |
12,105,898
+228,479
| +2% | +$24.7M | 0.17% | 129 |
|
|
2019
Q3 | $1.16B | Sell |
11,877,419
-2,207,933
| -16% | -$216M | 0.16% | 140 |
|
|
2019
Q2 | $1.84B | Sell |
14,085,352
-75,257
| -0.5% | -$9.86M | 0.26% | 92 |
|
|
2019
Q1 | $1.91B | Sell |
14,160,609
-3,511,876
| -20% | -$475M | 0.28% | 81 |
|
|
2018
Q4 | $1.72B | Sell |
17,672,485
-3,197,655
| -15% | -$311M | 0.29% | 84 |
|
|
2018
Q3 | $2.9B | Sell |
20,870,140
-1,180,688
| -5% | -$164M | 0.42% | 47 |
|
|
2018
Q2 | $2.74B | Buy |
22,050,828
+1,217,537
| +6% | +$151M | 0.42% | 47 |
|
|
2018
Q1 | $2.32B | Sell |
20,833,291
-173,497
| -0.8% | -$19.3M | 0.37% | 60 |
|
|
2017
Q4 | $2.51B | Sell |
21,006,788
-1,274,860
| -6% | -$152M | 0.41% | 54 |
|
|
2017
Q3 | $3.13B | Sell |
22,281,648
-537,207
| -2% | -$75.4M | 0.53% | 33 |
|
|
2017
Q2 | $2.78B | Buy |
22,818,855
+3,533,117
| +18% | +$430M | 0.5% | 35 |
|
|
2017
Q1 | $2.34B | Sell |
19,285,738
-1,801,682
| -9% | -$218M | 0.44% | 45 |
|
|
2016
Q4 | $2.58B | Buy |
21,087,420
+1,722,986
| +9% | +$211M | 0.51% | 37 |
|
|
2016
Q3 | $2.37B | Sell |
19,364,434
-379,455
| -2% | -$46.5M | 0.48% | 44 |
|
|
2016
Q2 | $2.31B | Sell |
19,743,889
-8,470,497
| -30% | -$989M | 0.49% | 40 |
|
|
2016
Q1 | $3.93B | Sell |
28,214,386
-81,041
| -0.3% | -$11.3M | 0.84% | 17 |
|
|
2015
Q4 | $5.4B | Buy |
28,295,427
+353,706
| +1% | +$67.5M | 1.14% | 11 |
|
|
2015
Q3 | $4.37B | Buy |
27,941,721
+1,739,186
| +7% | +$272M | 0.97% | 11 |
|
|
2015
Q2 | $4.74B | Buy |
26,202,535
+4,127,409
| +19% | +$746M | 0.97% | 13 |
|
|
2015
Q1 | $3.83B | Buy |
22,075,126
+1,899,735
| +9% | +$329M | 0.79% | 18 |
|
|
2014
Q4 | $3.73B | Buy |
20,175,391
+466,737
| +2% | +$86.4M | 0.79% | 18 |
|
|
2014
Q3 | $3.27B | Buy |
19,708,654
+2,405,193
| +14% | +$399M | 0.71% | 17 |
|
|
2014
Q2 | $2.7B | Buy |
17,303,461
+1,829,752
| +12% | +$286M | 0.58% | 28 |
|
|
2014
Q1 | $2.35B | Buy |
15,473,709
+586,401
| +4% | +$89.2M | 0.53% | 35 |
|
|
2013
Q4 | $1.98B | Sell |
14,887,308
-636,544
| -4% | -$84.7M | 0.45% | 47 |
|
|
2013
Q3 | $1.8B | Sell |
15,523,852
-1,395,225
| -8% | -$162M | 0.45% | 49 |
|
|
2013
Q2 | $1.56B | Buy |
+16,919,077
| New | +$1.56B | 0.42% | 54 |
|